Abstract:Our aim was to explore the clinical application value of high-intensity focused ultrasound (HIFU) therapy for tubal pregnancy. Forty hospitalized patients with tubal pregnancies (28 cases of non-ruptured tubal pregnancy and 12 cases of ruptured tubal pregnancy) were selected to receive HIFU therapy. Serum human chorionic gonadotropin (beta-HCG) concentrations were compared before and after treatment. Serum beta-HCG was measured weekly and patients received observation only if the concentration decreased by 15% or more, compared with the previous value. Patients were given supplement HIFU therapy if the decrease in the serum beta-HCG was <15% within two weeks. Ultrasound was used to detect the volume changes in the ectopic lesions before and after treatment, and changes in vital signs and complications were recorded. Contrast-enhanced ultrasonography was used to assess fallopian tube patency after treatment. HIFU treatment was successful in 33 of the 40 patients (82%). Seven patients failed HIFU treatment and received surgical therapy (18%). Before and after treatment, serum beta-HCG concentrations and lesion volume were significantly different (P < 0.05, P < 0.01, respectively). Post-treatment tubal contrast-enhanced ultrasonography showed tubal patency on the affected side in 21 cases (64%) at six months and in 27 cases (82%) at 12 months. In conclusion, HIFU is safe and effective, and can be a treatment option for tubal pregnancy.

OC20.08: Non‐invasive high‐intensity focused ultrasound treatment for Twin–twin transfusion syndrome: preclinical application on a pregnant monkey model

Initial Feasibility Study on Tomographic Ultrasound Imaging in Normal Fetuses

OP08.01: Perinatal outcomes of early Twin–twin transfusion syndrome treated with laser: an international multicentre study

OC20.04: Perinatal outcomes of early Twin–twin transfusion syndrome: an international multicentre study

Influence on Monkeys Generative Physiology after Terminating Early Pregnancy by Focused Ultrasound Beams

OC20.05: A randomised controlled trial in China: microwave ablation versus radiofrequency ablation for fetal reduction in monochorionic twin pregnancies

OC03.07: *The effect of entry technique on chorioamniotic membrane separation in fetoscopic laser photocoagulation for Twin–twin transfusion syndrome

EP14.20: Current experience with laser therapy for Twin–twin transfusion syndrome treatment in university and public hospitals in Chile

EP18.06: Outcomes of cytogenetic analysis during fetoscopic selective laser photocoagulation for Twin–twin transfusion syndrome

Clinical value of high-intensity focused ultrasound in fetal reduction

OC20.02: Risk of acute feto‐fetal transfusion in basic clinical subtypes of monochorionic twins

EP10.15: Prediction of dual twin survival after laser for Twin–twin transfusion syndrome

OP08.08: Predictors of single and double survival after laser ablation for early Twin–twin transfusion syndrome

OC02.06: Fetal and neonatal brain injury following laser ablation for TTTS as detected by pre‐ and postnatal brain imaging

EP10.07: Feasibility of fetoscopic laser photocoagulation for Twin–twin transfusion syndrome with fairly close cord insertion sites of the twins

EP10.08: Adverse outcomes in monochorionic twins with amniotic fluid abnormalities without Twin–twin transfusion syndrome

EP14.21: Impact of selective fetal growth restriction on survival after fetoscopic laser ablation in Twin–twin transfusion syndrome (TTTS)

A preliminary clinical study on high-intensity focused ultrasound therapy for tubal pregnancy.

EP24.08: How safe is high‐intensity focused ultrasound? An intriguing solution for obstetric and gynecological diseases: a systematic review

Application progress of prenatal ultrasound in twin-twin transfusion syndrome

EP14.11: Maternal cardiovascular dynamics in twin pregnancies complicated by Twin–twin transfusion syndrome